-
Oct 18, 2024 | 
theatrethoughtsaus.online | Bali Padda
Written by Isabella McDermott. Directed by Bali PaddaReviewed by Mary Anne ReidOld Fitz Theatre, WoolloomoolooUntil October 26th, 2024The production of Champions at the Old Fitz Theatre in Sydney is the Australian premiere of a work by talented young Kiwi playwright Isabella McDermott. The champions of the title are four artists nominated for a prestigious art prize (the Archie) that will deliver the winner $50,000 plus a massive career boost.
-
Sep 25, 2024 | 
upnext.com.au | Rajiv Joseph |Bali Padda
Riverside Theatres presents the iconic, ARIA award-winning musical duo, Katie Noonan and Karin Schaupp in a special, one-night-only performance of their highly anticipated new album, Songs of the Southern Skies Volume 2 at Riverside Theatre on Saturday 26 October.
-
Sep 18, 2024 | 
upnext.com.au | Rajiv Joseph |Bali Padda
Inspired by historical events, a royal scandal ignites a blistering fire between the steely Queen Mother and her children’s doting nanny in Melanie Tait’s new comedic drama, The Queen’s Nanny. The production comes to Wollongong direct from its world premiere season at Sydney’s Ensemble Theatre.
-
Sep 4, 2024 | 
upnext.com.au | Rajiv Joseph |Bali Padda
Merrigong Theatre Companybrings National Theatre of Parramatta's Guards at the Taj to the Illawarra Performing Arts Centre from 19 to 21 September. Set in India in 1648, Guards at the Taj follows best friends and guards in Hindustani ruler Shah Jahan's Imperial Army, Humayun and Babur. Humayun, a sternly loyal second-generation civil servant, feels compelled to follow orders to appease his father, whilst a sensitive and inquisitive Babur is more sceptical.
-
Sep 3, 2024 | 
artshub.com.au | Bali Padda
Merrigong Theatre Companybring National Theatre of Parramatta’s Guards at the Taj to the Illawarra Performing Arts Centre from 19 to 21 September. Set in India in 1648, Guards at the Taj follows best friends and guards in Hindustani ruler Shah Jahan’s Imperial Army, Humayun and Babur. Humayun, a sternly loyal second-generation civil servant, feels compelled to follow orders to appease his father, whilst a sensitive and inquisitive Babur is more sceptical.
-
Nov 27, 2023 | 
imd.org | Philip T. Levy |Michael Skapinker |Sudhanshu Sarronwala |Bali Padda
The Church of England has moved away from engagement and sold its fossil fuel shares, but to whose benefit? The shares have most likely been bought by investors who care little about climate change. One pension fundâs pioneering approach may provide a better alternative.
-
Nov 6, 2023 | 
imd.org | Sudhanshu Sarronwala |Bali Padda |John Elkington |George Kohlrieser
It’s nearly 30 years since John Elkington first posed the concept of the “triple bottom line” (TBL) in his milestone book Cannibals with Forks. Moving beyond shareholder and financial value alone, Elkington postulated that success in this century would be determined by companies that look at three bottom lines – the economic, the ecological, and the social.
-
Nov 2, 2023 | 
imd.org | Goutam Challagalla |Raphaël Grieco |Bali Padda |John Elkington
Less than a year after generative AI began to come to the fore, one-third of companies say they are already using it regularly in at least one business function.1 While executives may think that Generative AI is synonymous with ChatGPT and can be only used to generate text, it is capable of creating images and audio as well, offering the potential to transform work processes across marketing, customer services, supply chain, HR, and other functions.
-
Oct 30, 2023 | 
imd.org | Bali Padda |John Elkington |George Kohlrieser |Amanda Williams
In the early years of this century, the UK national postal service centralized and automated its financial reporting systems for thousands of post offices around the country, typically run by small, independent business owners, known as sub-postmasters. The project, supplied by Fujitsu, was called Horizon. After the roll-out, many of the sub-postmasters began reporting bugs in the system, often registering a significant but incorrect shortfall in takings.
-
Oct 26, 2023 | 
imd.org | Sudhanshu Sarronwala |Sean Meehan |Bali Padda |Sigvald Harryson
As the father of a cancer-surviving son, these days I often find myself investigating any new forms of treatment that may be of value for patients like him. That’s just one driving force behind my enthusiasm for the growing use of AI in the development and efficacy of immunotherapy. One significant plus to AI across the spectrum of cancer treatments is a simple matter of speed.
